Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Palantir Stock Is Stuck in a Trading Range. Here’s How It Could Spark Higher.

By Chris Lau, InvestorPlace Contributor

PLTR stock is stuck in a narrow trading range, unable to hold a rally because of increasing nervousness surrounding the technology sector.

QuantumScape Stock Is a Bet on a Future That Is Getting Nearer

By Chris Lau, InvestorPlace Contributor

QS shares are finding support at the $21 level as speculators bet it will come up with advancements in batteries in EVs.

7 Hedge Fund Victims That Could Join the List of Meme Stock Favorites

By Chris Lau, InvestorPlace Contributor

Buy these meme stocks as bulls once again prepare to squeeze the short-selling hedge funds betting on the wrong side of the trade.

AMC Stock May Fall Hard if Momentum Fades

By Chris Lau, InvestorPlace Contributor

Positive sentiment if lifting AMC stock but once markets lose interest and stop buying the stock, the downside risk is high.

Why Sundial Growers Is the Best Cannabis Bet

By Chris Lau, InvestorPlace Contributor

Sundial is debt-free and has plenty of cash on hand, with the strong balance sheet giving the company plenty of growth options.

Load More